Xortx Therapeutics Inc. [XRTX]

Source: 

Company Overview

XORTX Therapeutics is a late clinical-stage biotechnology company focused on identifying, developing and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as ADPKD and type 2 diabetic nephropathy, as well as AKI associate with respiratory virus infection.